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Correspondence
Caseous mitral valve calcification and concur-
rent hypertrophic obstructive cardiomyopathy:
A rare cause of stroke
Mitral annulus calcification (MAC) is a relatively common con-
dition with a prevalence of about 14%, often seen at old age and
results from degenerative changes in the mitral valve fibrous
skeleton [1]. An exceedingly rare and adverse variant of MAC is
the caseous calcification of the mitral annulus (CCMA), which
accounts for only 0.6% of all MAC cases [2]. It can be easily con-
fused with tumors, vegetations, or cysts; thus, often underdiag-
nosed and mistreated. CCMA in association with other
comorbidities can potentially increase the risk of cerebrovascular
accidents (CVA). Here, we present the first case of CCMA with con-
comitant hypertrophic obstructive cardiomyopathy (HOCM) pre-
senting with cardioembolic stroke complicated by hemorrhagic
conversion.
1. Case presentation
A 68-year-old woman with a past medical history of hyperten-
sion and HOCM presented to the emergency department (ED) with
sudden left-sided facial weakness and slurred speech for the last
2 h. She also complained of sudden onset of dizziness and difficulty
concentrating, while she was working from home, attempting to
sign into a zoom meeting. She noted that she was not able to sign
in, and was having trouble with her coordination and typing on her
computer.
In the ED, she was afebrile with a temperature of 98F, tachycar-
diac (heart rate 120) and hypotensive (90/60 mmHg). Her oxygen
saturation (SaO2) was 85% on room air. Her physical examination
was significant for right middle lung rhonchi, facial droop and gar-
bled speech. Her National Institutes of Health Stroke Scale (NIHSS)
was 4. Her cardiovascular examination revealed a pansystolic mur-
mur at the mitral area.
Laboratory investigation was significant for leukocytosis (white
blood cells count of 17.4  109/L). Rest of the blood work was
unremarkable. Her nasal swab real-time fluorescence polymerase
chain reaction (RT-PCR) for severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) returned negative. The computed
tomography (CT) head ruled out hemorrhagic stroke. Her brain
magnetic resonance imaging (MRI) was consistent with bihemi-
spheric cortical and subcortical embolic strokes. Electrocardiogram
(EKG) showed normal sinus rhythm. Transthoracic echocardio-
gram (TTE) revealed a hyperdynamic anterior ventricle, systolic
anterior motion of the mitral valve, peak resting left ventricular
outflow tract (LVOT) gradient of 84 mmHg and posterior mitral
leaflet mass suggestive of vegetation complicated by moderate-
to-severe mitral regurgitation. Her cardiac CT showed posterior
MV leaflet calcification (Fig. 1). Cardiac MRI was consistent with
LVEF of 82%; focal HOCM with LVOT obstruction and systolic ante-
rior motion of the mitral valve leaflet and moderate mitral valve
regurgitation (Figs. 2, 3) There was no delayed myocardial
enhancement to suggest scar, infarct, or infiltrative disorder.
She was placed on supplemental oxygen at 2 L/min via nasal
cannula and started on antibiotics for aspiration pneumonia. She
was emergently treated with tissue plasminogen activator (tPA),
suspecting cerebrovascular accident (CVA) in the right middle
cerebral artery (MCA) territory. She was admitted to the neurocrit-
ical unit for close neurological monitoring, stroke workup, and fur-
ther medical management.
Patient developed a sudden onset of headaches 6 h later. Her
neurological exam remained unchanged. A repeat CT head revealed
a large right frontal and temporal intracerebral hemorrhage asso-
ciated with right-sided subarachnoid hemorrhage (SAH) and right
to left midline shift. She was managed with supportive care and
started on a nicardipine drip. She also received hypertonic saline
for osmotic diuresis for goal sodium level of 155–160 mEq/L for
cerebral edema. She received a loop recorder and was ultimately
discharged to a rehabilitation center with residual weakness. On
follow-up, the biotel cardionet monitor recorded no episodes of
AF, heart block, pauses, or other arrhythmias.
2. Discussion
CCMA is a distinctive and special variant of MAC that results
from liquefactive necrosis of the posterior annulus of the mitral
valve and is usually considered a benign condition [1,2]. In rare
cases, however, it may compromise the normal function of the
mitral valve, subsequently causing regurgitation or mitral stenosis
[3]. The later can cause significant left ventricular inflow tract
obstruction. Other rare valvular complications of CCMA may also
predispose patients to left ventricular outflow obstruction (LVOT),
atrial fibrillation (AF), and aortic valve abnormalities [4]. It can also
lead to the same hemodynamic consequences of constrictive peri-
carditis. While all these complications significantly increase the
risk of CVA, we believe that CCMA independently carries a higher
risk of cerebrovascular complications especially in presence of
HOCM [1,3,5,6].
A review of 130 patients with CCMA reported a 19.2% preva-
lence of CVAs, significantly higher than seen with MAC alone
(11.8%) [7]. This highlights the importance of differentiating CCMA
from MAC to prevent dire consequences. The suggestive echocar-
diographic findings of CCMA include areas of decreased echogenic-
ity, a central echolucent zone, and the absence of acoustic
shadowing. Microscopically, CCMA is characterized by liquefaction
necrosis with amorphous eosinophilic acellular material sur-
rounded by lymphocytes and macrophages amid multiple small
calcifications [1]. Intriguingly, only four of the reported 25
(16.0%) patients with CCMA who suffered a CVA had a history of
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AF. This further indicates that CCMA might serve as an indepen-
dent risk factor for CVA.
The risk of stroke in patients with HOCM alone is merely 1.0%,
which is largely attributed to the high rate of AF in these patients
[8]. However, in our case, a biotel cardionet monitor recorded no
episodes of AF indicating that the hemodynamic instability cou-
pled with cardiac embolization was the repercussions elicited by
CCMA. We believe that embolization of the caseous necrotic debris
Fig. 1. CT scan showing pleural effusion and mitral annular calcification.
Fig. 2. Coronal section of cardiac MRI showing LVOT obstruction and mitral annular calcification.
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of the mitral annulus was the major cause of multifocal stroke in
our case. The stroke risk in our case was further precipitated by
the LVOT obstruction induced hemodynamic instability in pres-
ence of HOCM.
Our case also highlights the importance of early recognition of
this potentially fatal condition. Diagnosing CCMA is itself an oner-
ous diagnostic challenge due to its rarity and perplexing clinical
manifestations. Prompt detection and management of CCMA and
HOCM may aid in foiling adverse outcomes, such as CVA. Lesions
afflicting the posterior mitral annulus on echocardiography should
be evaluated through further imaging to rule out CCMA so that the
grave ramifications elicited by it can be prevented. In our case, a
definitive diagnosis was made with MRI and CT scan which ruled
out other causes and confirmed the presence of CCMA. This neces-
sitates the need for multimodality imaging to yield a definitive
diagnosis of CCMA. The patient also developed moderate to severe
mitral regurgitation due to prolonged CCMA. Previous studies have
shown that mitral regurgitation develops secondary to longstand-
ing MAC [9]. This grave valvular abnormality, along with the
patient’s history of HOCM and LVOT culminated in hemodynamic
instability and CVA.
It is unclear whether treating patients with CCMA prophylacti-
cally with valve replacement can reduce the risk of stroke. Also, the
risk of tPA associated hemorrhagic conversion of embolic stroke in
these patients warrants more studies on a larger scale. Current
studies focused on the imperativeness of conservative manage-
ment in treating early CCMA by controlling other cardiovascular
comorbidities (hypertension, dyslipidemia) and prevention of
complications such as arrhythmias [10,11]. Antithrombotic ther-
apy is reserved for patients with CVA and cardioembolic complica-
tions. Patients with symptomatic severe mitral regurgitation and
mitral stenosis are treated with surgical mitral valve replacement
as percutaneous mitral balloon valvuloplasty is generally not
effective. Due to a high risk of operative mortality a careful risk-
benefit evaluation is recommended.
3. Conclusion
In our case, CCMA along with concurrent HOCM and LVOT
obstruction resulted in hemodynamic instability leading to car-
dioembolic stroke and subsequent hemorrhagic conversion with
tPA. We, therefore, advocate for early recognition and considera-
tion of elective surgical resection of CCMA in patients with HOCM,
even in asymptomatic patients who are good surgical candidates.
Nevertheless, more studies are required to understand the patho-
genesis and the precise clinical course of CCMA in patients with
HOCM.
4. Learning objectives
CCMA along with concurrent HOCM and LVOT obstruction can
result in hemodynamic instability, leading to cardioembolic stroke
and subsequent hemorrhagic conversion with tPA. Early recogni-
tion and consideration of elective surgical resection of CCMA in
patients with HOCM, even in asymptomatic patients who are good
surgical candidates, therefore remains pivotal in avoiding potential
complications
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Fig. 3. Sagittal section of cardiac MRI showing LVOT obstruction and mitral annular calcification.
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